AdvanSource Biomaterials Corporation 

(Public, AMEX:ASB)   Watch this stock   
Find more results for ASB
Dec 17, 2009
Q2 2010 Earnings Conference Call - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin -103.86% -77.09%
Operating margin -104.63% -78.56%
EBITD margin - -67.53%
Return on average assets -27.22% -24.84%
Return on average equity -29.12% -27.93%
Employees 20 -

Address

229 Andover Street
Wilmington, MA 01887
United States - Map
+1-978-6570075 (Phone)
+1-978-6570074 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Discussion Group - Google Finance

AdvanSource Biomaterials Corporation discussed on blogs

Top Rising Stocks with Unusual Volume (Feb 8, 2010) - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 13 hours ago
BEST-Performing U.S. Stocks Year-to-Date as of Feb 8, 2010 ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 13 hours ago
RxNews Recap for Monday 02-08-10. Amgen (AMGN) jumps after hours ... - Mary Davila - BioMedReports.Com - Feb 8, 2010

Description

AdvanSource Biomaterials Corporation, formerly CardioTech International, Inc., develops polymer materials, which provides characteristics in the design and development of medical devices. The Company’s biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The Company manufactures and sells its polymers under the trade names ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, HydroThane and PolyBlend. The Company also manufactures and sells HydroThane polymers to medical device manufacturers. HydroThane is a thermoplastic, water-absorbing, polyurethane elastomer. It also manufactures specialty hydrophilic polyurethanes that are primarily sold to customers as part of exclusive arrangements. The Company manufactures polymers at its Massachusetts facility.

Officers and directors

Willaim J. O'Neill Jr.
Chairman of the Board
Age: 67
Bio & Compensation - Reuters
Michael F. Adams
President, Chief Executive Officer, Director
Age: 52
Bio & Compensation - Reuters
David C. Volpe
Acting Chief Financial Officer
Age: 54
Bio & Compensation - Reuters
Andrew M. Reed Ph.D.
Vice President - Science & Technology
Age: 56
Bio & Compensation - Reuters
Michael L. Barretti
Director
Age: 64
Bio & Compensation - Reuters
Anthony J. Armini Ph.D.
Director
Age: 71
Bio & Compensation - Reuters
Jeremiah E. Dorsey
Director
Age: 64
Bio & Compensation - Reuters